6,023 filings
Page 2 of 100
6-K
opa779xgrzox9 06vd
22 Mar 24
Director/pdmr Shareholding
12:17pm
6-K
18qpvt9yf2wvsd24
18 Mar 24
New Phase III Jemperli Data In Endometrial Cancer
9:56am
6-K
7verr6s 18cwd3
13 Mar 24
Director/pdmr Shareholding
1:15pm
6-K
u4gvmdj3xk pqipf
8 Mar 24
Board Committee Change
12:48pm
6-K
vcxsu8ffulzwy79nd1z
7 Mar 24
GSK Announces Positive Blenrep DREAMM-8 Results
6:13am
6-K
y8gbpd3vc8chx
6 Mar 24
VIIV Lai VS Oral Soc Data In Adherence-challenged
11:11am
6-K
5zppxkf8rjugq7h
5 Mar 24
GSK Annual Report 2023 on Form 20 F
1:09pm
IRAN
9yvwmxvcw083vqf1t
5 Mar 24
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:30pm
6-K
v01 yhxbo6
5 Mar 24
New VIIV La Formulation Potential 4-MONTH Dosing
6:10am
6-K
1fcl52vi7w0179
1 Mar 24
Total Voting Rights
10:29am
6-K
unmnvo
1 Mar 24
GSK Publishes Annual Report 2023
9:55am
6-K
iygh2xfwfr h895u5rak
29 Feb 24
Directorate Change
6:27am
6-K
zelz8qjl2nbjgmvks2bu
29 Feb 24
Statement: Zantac (Ranitidine) Litigation
6:27am
6-K
iox5ru
26 Feb 24
Director/pdmr Shareholding
10:38am
6-K
vyaztu 7s6tqmojz
26 Feb 24
GSK Announces Positive EAGLE-1 Headline Results
6:39am
6-K
yda0xeeci v031
22 Feb 24
Director/pdmr Shareholding
10:45am
6-K
3kzvo5fd 0ftt9
21 Feb 24
VIIV Lai Superior to Orals In Adherence-challenged
6:40am
6-K
bnmyyg1ikpys61z1zw4
20 Feb 24
Director/pdmr Shareholding
6:50am
6-K
bp013hpw478b5 thvwd5
15 Feb 24
Director/pdmr Shareholding
12:53pm